H-Index
85
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
12%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

Hypermethylation of IGSF4 gene for noninvasive prenatal diagnosis of thalassemia

Tian Gao, Yanli Nie, Hua Hu, Zhiqing Liang

Med Sci Monit 2012; 18(1): BR33-40

DOI: 10.12659/MSM.882199

Available online:

Published: 2011-12-22


#882199

Background:    For patients with pregnancy-induced thalassemia, fetal cord blood or amniotic fluid is invasively collected in the traditional diagnosis and prediction of thalassemia. However, there is no specific molecular target in the diagnosis of thalassemia using fetal DNA from the plasma of pregnant women.
    Material/Methods:    The promoter of cell surface adhesion molecule (IGSF4) gene was found to be down-regulated in patients with homozygous thalassemia, and the expression of IGSF4 was closely associated with the methylation of its promoter. In the present study, mass spectrometric sequencing of methylation was performed using MassARRAY to detect the 12 CpG sites in the promoter of IGSF4 gene.
    Results:    The methylation degree of these 12 CpG sites was significantly higher than that in healthy subjects (P<0.05). Hierarchical clustering was done in 23 patients with thalassemia and 5 healthy individuals. Results revealed the promoter of IGSF4 gene was highly methylated in thalassemia patients, which was dramatically different from that in healthy subjects (P<0.05). Methylation-specific PCR (MSP) was employed to confirm the methylation of the promoter of IGSF4 gene and results were consistence with those obtained in sequencing with MassARRAY. Real-time PCR showed, when compared with heterozygous subjects, the expression of IGSF4 was significantly down-regulated in thalassemia patients (ratio=0.18).
    Conclusions:    The expression of IGSF4 was closely related to the methylation of its promoter, suggesting the methylation of IGSF4 gene is tissue-specific for thalassemia. These findings provide evidence for the non-invasive prenatal diagnosis of thalassemia in terms of epigenetics.

Keywords: Promoter Regions, Genetic - genetics, Real-Time Polymerase Chain Reaction, Prenatal Diagnosis - methods, Pregnancy, Polymerase Chain Reaction, Mass Spectrometry, Immunoglobulins - genetics, DNA Primers - genetics, DNA Methylation - genetics, CpG Islands - genetics, Cluster Analysis, Cell Adhesion Molecules - genetics, Sequence Analysis, DNA - methods, Sulfites, Thalassemia - diagnosis



Back